The Patent Finder

Nibec Co., Ltd.

9 patents currently held · Updated Nov 22, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Mar 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 22, 2027.

Recent changes

  • 1 of the patents on this record was granted since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,349,804Bone Graft and Scaffolding Materials Immobilized with Type I Collagen Binding Peptides
In force
 · High confidence
In forceHigh confidence
US 10,821,065Peptide for Inhibiting Biofilms
In force
 · High confidence
In forceHigh confidence
US 12,486,303Novel Use of Peptide for Inhibiting Functions and Expressions of Multiple Disease Biomarkers
In force
 · Medium confidence
In forceMedium confidence
US 11,384,120Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof
In force
 · USPTO record
In forceUSPTO record
US 12,161,518Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with same
In force
 · USPTO record
In forceUSPTO record
US 12,655,413Fragmented GRS Polypeptide and Variant Thereof, and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,545,704Peptide for Treating Inflammation and Wounds
In force
 · High confidence
In forceHigh confidence
US 12,698,313Bone Morphogenetic PROTEIN-9 and -10 Variants with Enhanced Therapeutic Effect Due to Reduced Side Effects of Ectopic Ossification and Pharmaceutical Composition Comprising Same
In force
 · High confidence
In forceHigh confidence
US 12,780,940Protein Comprising Antibody for Targeting Oncogenic Protein or Single Chain Fragment Variable Thereof and Cancer Cell Penetrating Peptide, and Use of the Same
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 2 abandoned

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/836,830Bioabsorbable and Photocurable Composition, Bioabsorbable Guided Tissue Regeneration Composition, and Grafting Method Using SameFeb 14, 2023Pending
18/836,118Peptide Having Antibacterial, Anti-Inflammatory or Tissue Regeneration Ability and Use ThereofFeb 14, 2023Pending
18/697,475Peptide for Penetrating Blood-Brain Barrier and Use ThereofSep 30, 2022Pending
18/568,180Bio Protac Protein Having Intracellular Delivery Function, and Pharmaceutical Composition Comprising SameJun 10, 2022Pending
18/567,167Nanoparticle Comprising Peptide-Lipid Conjugate for Delivering Oligonucleotide into Target Cell and Pharmaceutical Composition Comprising SameJun 10, 2022Pending
18/262,543Peptide for Preventing and Treating FibrosisJan 24, 2022Pending
17/272,010Novel Use of Peptide for Inhibiting Functions and Expressions of Multiple Disease BiomarkersAug 29, 2019Abandoned
16/755,370Method for Selecting Highly Efficient Stem Cell, Using Protein Marker GRP78Oct 15, 2018Pending
16/625,692Peptide for Inhibiting Bone ResorptionJun 19, 2018Abandoned
16/623,167Integral Biomaterial for Regeneration of Bone Tissue and Fabrication Method ThereforJul 27, 2017Pending
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited